Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

  title={Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.},
  author={John Otasowie and Xavier Castells and Umonoibalo P Ehimare and Clare Smith},
  journal={The Cochrane database of systematic reviews},
BACKGROUND Attention deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder of childhood onset, which may persist into adulthood. ADHD has a significant impact on a child's daily life, affecting relationships and academic performance. Its core symptoms include developmentally inappropriate levels of inattention, hyperactivity, and impulsive behaviour. Tricyclic antidepressants (TCAs) are sometimes used as second line of treatment in the reduction of ADHD symptoms in… 

Figures from this paper

A review of Cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorder
Treatment with tricyclic antidepressants, amphetamine, and methylphenidate in children and adolescents with ADHD seems to present positive effects and higher rates of minor adverse events when compared to placebo.
Treatment-resistant attention-deficit hyperactivity disorder: Clinical significance, concept, and management
It is suggested that the more ideal strategy of defining treatment resistance should consider the improvement of ADHD symptoms and the global functioning simultaneously, and the optimal medication adjustment or the combination of medications and psychotherapy may be the potential therapeutic strategy for treatment-resistant ADHD.
Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment
Compared to placebo, selected antidepressants can be efficacious in the acute treatment of some common psychiatric disorders, although statistically significant differences do not always translate into clinically significant results.
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD)
Strategies to manage stimulant-refractory ADHD are discussed, based on the recommendations advanced in clinical guidelines, knowledge of expert practice in the field, and own clinical recommendations, informed by a comprehensive literature search in PubMed, PsycInfo, EMBASE + EMBases classic, OVID Medline, and Web of Science.
The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials
This systematic review and network meta-analysis will compare the efficacy and safety of treatments used for ADHD in children and adolescents and assist patients, clinicians and healthcare providers to make evidence-based decisions regarding treatment selection.
Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder
  • G. BahnYoung Sik Lee Y. Joung
  • Psychology, Medicine
    Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry
  • 2020
The Korean practice parameter introduces not only general information for the diagnosis and treatment of adult ADHD on a global scale, but also the process of diagnosis and Treatment options tailored to the Korean population.
Treatment Approaches to Attention Deficit Hyperactivity Disorder.
Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients
In the short term, pharmacological treatment provides moderate–high symptom relief, is safe and shows lower treatment discontinuation than placebo, suggesting a suitable risk-benefit balance, particularly with psychostimulants.


Attention-Deficit/Hyperactivity Disorder: A Selective Overview
The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder.
It is suggested that comorbidity with a tic disorder has a limited effect on ADHD outcome, and tic disorders had little effect on the psychosocial functioning of subjects with ADHD.
Prevalence of attention-deficit hyperactivity disorders in students. Comparison between DSM-IV and neuropsychological criteria.
It is concluded that the use of DSM-IV criteria probably overestimates the prevalence of ADHD, since it detects another behavioral disorders and may be useful as screening, since they have adequate pre-testing performance.
ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments.
The results extend to adolescents well-documented findings in children, indicating that ADHD is quite prevalent in early adolescence and affected youths are at high risk for impairment and dysfunction in multiple domains.
The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
It is suggested that desipramine may be a useful alternative for the treatment of symptoms of ADHD in children with TS and clonidine showed a statistically significant improvement on a global linear analogue scale, but not on the Hopkins Motor/Vocal Tic Severity scale, the Tourette Syndrome Severity Scale, or the Yale Global Tic Scale.
A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.
Data suggest that NT is effective in reducing symptoms not only of ADHD but also of oppositionality, and this group of children and adolescents tolerated robust dosing of NT well, with few clinical or cardiovascular adverse events.
Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis
Critical issues about etiologic subtypes of ADHD that may involve dopamine are identified, methods that could be used to address these issues are discussed, and old and new theories that may direct research in this area in the future are reviewed.